NEXGEL Reports Strong Q1 2025 Financial Growth

Nexgel, Inc. ( (NXGL) ) has released its Q1 earnings. Here is a breakdown of the information Nexgel, Inc. presented to its investors.

NEXGEL, Inc., based in Langhorne, Pennsylvania, is a prominent provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, known for its innovative electron-beam, cross-linked hydrogels.

In its first quarter of 2025, NEXGEL reported significant financial growth with a revenue increase of 121% year-over-year, totaling $2.81 million. The company also achieved a notable improvement in gross profit margin, which rose to 42.4% from 12.6% in the same quarter of the previous year.

Key financial highlights from the quarter include a gross profit of $1.19 million, up from $0.16 million in Q1 2024, and a reduced net loss of $0.71 million compared to $0.85 million in the previous year. The company’s EBITDA and adjusted EBITDA also showed improvement, narrowing to losses of $0.54 million and $0.47 million, respectively.

Despite the net loss, NEXGEL’s management remains optimistic about future growth. The company plans to leverage its existing customer base and new product launches to achieve its 2025 revenue target of $13 million and aims to reach positive EBITDA within the year.